Genelux Corp. (GNLX) intrinsic value & 10-year financials
Genelux Corp. (GNLX) has a Graham intrinsic value of $128.77 per share. At $2.42 on Oct 17, 2026, the stock trades 98% below that value. Over the last 5 fiscal years revenue shrank 91.0% a year to $8.0K, with an average return on invested capital of -40.8%.
- Graham intrinsic value
- $128.77
- Share price (Oct 17, 2026)
- $2.42
- Price vs Graham value
- 98% below
- Market cap
- $90.0M
- Revenue (FY2025)
- $8.0K
- Revenue growth (5-yr CAGR)
- -91.0%
- ROIC (10-yr avg)
- -40.8%
- Free cash flow (FY2025)
- -$26.4M
GNLX 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $8.0K | -$32.1M | -$0.86 | -$26.4M | -415175.0% | -240.6% |
| FY2024 | $8.0K | -$29.9M | -$0.95 | -$21.6M | -396200.0% | -186.3% |
| FY2023 | $170.0K | -$28.3M | -$1.16 | -$21.3M | -14214.7% | 255.0% |
| FY2022 | $11.1M | -$5.2M | -$0.57 | -$3.6M | -27.2% | 8.6% |
| FY2021 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
GENELUX Corp revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
GENELUX Corp has historically struggled to out-earn its cost of capital, averaging just 1.7% ROIC.
GENELUX Corp capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, GENELUX Corp is modeled at -91.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $128.77 per share.